Shopping Cart
Remove All
Your shopping cart is currently empty
p38 MAPK inhibitor is a potent inhibitor of p38 MAP kinase (IC50 = 35 nM). It inhibits senescence induced by the oncogene RAS.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 500 μg | $54 | In Stock | In Stock | |
| 1 mg | $88 | In Stock | In Stock | |
| 5 mg | $309 | In Stock | In Stock | |
| 10 mg | $483 | In Stock | In Stock | |
| 25 mg | $713 | In Stock | In Stock | |
| 50 mg | $978 | In Stock | In Stock | |
| 100 mg | $1,300 | - | In Stock | |
| 200 mg | $1,770 | - | In Stock |
| Description | p38 MAPK inhibitor is a potent inhibitor of p38 MAP kinase (IC50 = 35 nM). It inhibits senescence induced by the oncogene RAS. |
| Targets&IC50 | p38:35 nM |
| Molecular Weight | 365.79 |
| Formula | C20H13ClFN3O |
| Cas No. | 219138-24-6 |
| Smiles | O=C1C(=C(NN1C2=CC=C(Cl)C=C2)C=3C=CN=CC3)C4=CC=C(F)C=C4 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | Ethanol: 0.3 mg/mL (0.82 mM), Sonication is recommended. DMF: 5 mg/mL (13.67 mM), Sonication is recommended. DMSO: 10 mg/mL (27.34 mM), Sonication is recommended. DMSO:PBS(pH7.2) (1:1): 0.5 mg/mL (1.37 mM), Sonication is recommended. |
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 1 mg/mL (2.73 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.